Cooley advised Redx Pharma on the deal while Ropes & Gray has advised Jounce Therapeutics, Inc. Redx Pharma, a UK clinical-stage biotechnology company, announced its all share...
You must be a Standard 1 Year member to access this content.
Dechert advised Chiesi Farmaceutici S.p.A. Gide Loyrette Nouel represented BNP Paribas. Amryt Pharma was advised by Cooley. Italian pharmaceutical company Chiesi Farmaceutici has signed a definitive agreement to acquire Amryt Pharma in...
You must be a Standard 1 Year member to access this content.
Cooley advised Biote on the deal. Biote, a medical practice-building business within the hormone optimization space, announced its definitive business combination agreement with special purpose acquisition company...
You must be a Standard 1 Year member to access this content.
Cooley and Arendt advised Alvotech Holdings, while Kirkland & Ellis, working alongside Walkers and King & Spalding and Elvinger Hoss Prussen, advised Oaktree Acquisition Corp. II...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Exscientia on the deal while Goodwin Procter represented Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, BofA Securities and Barclays Capital...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Exscientia on the deal. Exscientia, a clinical-stage pharmatech company, announced its $225 million Series D funding round led by SoftBank Vision Fund 2, which...
You must be a Standard 1 Year member to access this content.
Cooley LLP, Herzog Fox & Neeman, Saiber LLC, Wiggin LLP and Carey Olsen advised Super Group on the deal while Blank Rome LLP, CMS, Ropes &...
You must be a Standard 1 Year member to access this content.
